SCHEMBL8102463

SCHEMBL8102463

C=CCOC(=O)c1ccc(NC(=O)C(=NOC)c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 7/20 0.47
RARA P10276 7/20 0.47
CYP3A4 P08684 6/20 0.47
RARB P10826 6/20 0.47
RARG P13631 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
CYP26B1 Q9NR63 3/20 0.45
RXRA P19793 7/20 0.45
RXRB P28702 7/20 0.45
RXRG P48443 6/20 0.45
PGR P06401 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
TBXA2R P21731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8102461 1.00 CYP26A1 (0.47) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7876777 0.90 CYP26A1 (0.48) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7876774 0.90 CYP26A1 (0.48) CYP26A1RARACYP3A4RARBRARG
SCHEMBL8092877 0.89 CYP26A1 (0.44) CYP26A1RARACYP3A4RARBRARG
SCHEMBL8092876 0.89 CYP26A1 (0.44) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7876772 0.88 RARA (0.42) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7884585 0.88 CYP26A1 (0.46) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7876775 0.88 RARA (0.42) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7885952 0.88 RARA (0.42) CYP26A1RARACYP3A4RARBRARG
SCHEMBL7884583 0.88 CYP26A1 (0.46) CYP26A1RARACYP3A4RARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051243-A USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-04-18 US disclosed
US-5709867-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, AND OPHTHALMOLOGICAL DISORDERS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 1998-01-20 US disclosed